Porter C W, Cavanaugh P F, Stolowich N, Ganis B, Kelly E, Bergeron R J
Cancer Res. 1985 May;45(5):2050-7.
Eleven novel spermidine (SPD) derivatives were synthesized as potential anticancer agents and evaluated for their ability to compete with [3H]SPD for cellular uptake, to inhibit cell growth, to affect polyamine biosynthesis, to suppress enzyme activity, and to substitute for SPD in supporting growth of cultured L1210 leukemia cells. The compounds included a series of N4-SPD derivatives (N4-methyl-SPD, N4-ethyl-SPD, N4-acetyl-SPD, N4-hexyl-SPD, N4-hexanoyl-SPD, N4-benzyl-SPD, and N4-benzoyl-SPD) and a series of N1,N8-SPD derivatives [N1,N8-bis(ethyl)-SPD, N1,N8-bis(acetyl)-SPD, N1,N8-bis(propyl)-SPD, and N1,N8-bis(propionyl)-SPD]. Uptake studies revealed N4-alkyl derivatives to be the most effective competitive inhibitors of [3H]SPD uptake (Ki, 26 to 43 microM) followed by N1,N8-alkyl derivatives (Ki, 71 to 115 microM), then N4-acyl derivatives (Ki, 115 to greater than 500 microM), and N1,N8-acyl derivatives (Ki, greater than 500 microM). The data indicate the relative importance of the terminal amines and of charge as determinants of cellular uptake. Of the 11 derivatives, only N4-hexyl-SPD, N1,N8-bis(ethyl)-SPD, and N1,N8-bis(propyl)-SPD demonstrated antiproliferative activity at 0.1 mM with 50%-inhibitory concentration values at 48 h of 30, 40, and 50 microM, respectively. In the case of the N1,N8-SPD derivatives, recovery from growth inhibition was enhanced considerably by exogenous SPD, suggesting involvement of polyamine depletion. At 10 to 30 microM, both N1,N8-bis(ethyl)-SPD and N1,N8-bis(propyl)-SPD (but not N4-hexyl-SPD) inhibited polyamine biosynthesis as indicated by significant reductions in polyamine pools and in biosynthetic enzyme activities. The more effective of the two, N1,N8-bis(ethyl)-SPD, depleted intracellular putrescine and SPD and reduced spermine by approximately 50% at 96 h and decreased ornithine and S-adenosylmethionine decarboxylase activities by 98 and 62%, respectively. Since neither derivative (at 5 mM) directly inhibited these enzymes from untreated cell extracts by significantly more than SPD itself, it is suspected that they act by regulating enzyme levels. As a measure of regulatory potential of the derivatives, ornithine decarboxylase was assayed in cells treated for 24 h and compared to the effects of 10 microM SPD which reduced the enzyme activity by 80%. None of the N4-SPD derivatives affected ornithine decarboxylase activity, while N1,N8-bis(ethyl)- and (propyl)-SPD were nearly as effective as SPD. Apparently, the central amine of the molecule is critical for regulatory function.(ABSTRACT TRUNCATED AT 400 WORDS)
合成了11种新型亚精胺(SPD)衍生物作为潜在的抗癌剂,并评估了它们与[3H]SPD竞争细胞摄取、抑制细胞生长、影响多胺生物合成、抑制酶活性以及替代SPD支持培养的L1210白血病细胞生长的能力。这些化合物包括一系列N4-SPD衍生物(N4-甲基-SPD、N4-乙基-SPD、N4-乙酰基-SPD、N4-己基-SPD、N4-己酰基-SPD、N4-苄基-SPD和N4-苯甲酰基-SPD)和一系列N1,N8-SPD衍生物[N1,N8-双(乙基)-SPD、N1,N8-双(乙酰基)-SPD、N1,N8-双(丙基)-SPD和N1,N8-双(丙酰基)-SPD]。摄取研究表明,N4-烷基衍生物是[3H]SPD摄取最有效的竞争性抑制剂(Ki,26至43 microM),其次是N1,N8-烷基衍生物(Ki,71至115 microM),然后是N4-酰基衍生物(Ki,115至大于500 microM)和N1,N8-酰基衍生物(Ki,大于500 microM)。数据表明末端胺和电荷作为细胞摄取决定因素的相对重要性。在这11种衍生物中,只有N4-己基-SPD、N1,N8-双(乙基)-SPD和N1,N8-双(丙基)-SPD在0.1 mM时表现出抗增殖活性,48小时的50%抑制浓度值分别为30、40和50 microM。对于N1,N8-SPD衍生物,外源性SPD可显著增强其从生长抑制中的恢复,表明多胺耗竭参与其中。在10至30 microM时,N1,N8-双(乙基)-SPD和N1,N8-双(丙基)-SPD(但不是N4-己基-SPD)均抑制多胺生物合成,多胺池和生物合成酶活性显著降低表明了这一点。两者中更有效的N1,N8-双(乙基)-SPD在96小时时使细胞内腐胺和SPD耗竭,并使精胺减少约50%,鸟氨酸和S-腺苷甲硫氨酸脱羧酶活性分别降低98%和62%。由于两种衍生物(5 mM时)对未处理细胞提取物中的这些酶的直接抑制作用均未显著超过SPD本身,因此怀疑它们通过调节酶水平起作用。作为衍生物调节潜力的一项指标,在处理24小时的细胞中测定鸟氨酸脱羧酶,并与10 microM SPD的作用进行比较,后者使酶活性降低80%。没有一种N4-SPD衍生物影响鸟氨酸脱羧酶活性,而N1,N8-双(乙基)-和(丙基)-SPD的效果几乎与SPD一样。显然,分子的中心胺对于调节功能至关重要。(摘要截短至400字)